Source: "Sun Pharma" and includes its subsidiaries and/or associate companies) announced that the U.S. Food and Drug Administration (FDA) has approved ILUMYA™ (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ILUMYA selectively binds to the p19 subunit of IL-23 and…...
Cigna to Acquire Express Scripts for $67 Billion
Source: Drives greater affordability and connectivity with customers and their health care providers, while making health care simpler Creates an expanded portfolio of health services with greater choice, alignment and value across a proven services platform Expands distribution of health services for employers, health plans and government agencies Delivers first…...